Gentian Diagnostics AS (GENT) — Capital Reinvestment Ratio
Gentian Diagnostics AS (GENT) has a Capital Reinvestment Ratio of 0.25x as of December 2025, meaning it reinvests 0% of its operating cash flow (Nkr42.59 Million) in capital expenditures (Nkr10.76 Million). Check Gentian Diagnostics AS tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Gentian Diagnostics AS Capital Reinvestment Ratio (2013–2025)
This chart tracks Gentian Diagnostics AS's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Gentian Diagnostics AS cash conversion from operations.
Annual Capital Reinvestment Ratio for Gentian Diagnostics AS (2013–2025)
Year-by-year Capital Reinvestment Ratio for Gentian Diagnostics AS from 2013 to 2025. See Gentian Diagnostics AS (GENT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | Nkr42.59 Million | Nkr10.76 Million | ▼ -69.0% |
| 2024 | 0.81x | Nkr13.46 Million | Nkr10.95 Million | ▲ +180.3% |
| 2023 | 0.29x | Nkr15.46 Million | Nkr4.49 Million | ▼ -79.8% |
| 2013 | 1.44x | Nkr2.43 Million | Nkr3.49 Million | — |